| Ident. | Authors (with country if any) | Title |
|---|
| 000038 |
D. M. Johnstone [Australie] ; N. El Massri [Australie] ; C. Moro [France] ; S. Spana [Australie] ; X. S. Wang [Australie] ; N. Torres [France] ; C. Chabrol [France] ; X. De Jaeger [France] ; F. Reinhart [France] ; S. Purushothuman [Australie] ; A.-L. Benabid [France] ; J. Stone [Australie] ; J. Mitrofanis [Australie] | INDIRECT APPLICATION OF NEAR INFRARED LIGHT INDUCES NEUROPROTECTION IN A MOUSE MODEL OF PARKINSONISM - AN ABSCOPAL NEUROPROTECTIVE EFFECT |
| 000193 |
J. Bove [Espagne] ; C. Perier [Espagne] | NEUROTOXIN-BASED MODELS OF PARKINSON'S DISEASE |
| 000236 |
H. Iderberg [Suède] ; V. Francardo [Suède] ; E. Y. Pioll [Royaume-Uni] | ANIMAL MODELS OF L-DOPA-INDUCED DYSKINESIA: AN UPDATE ON THE CURRENT OPTIONS |
| 000300 |
Rui D. S. Prediger [Brésil] ; Aderbal S. Jr Aguiar [Brésil] ; Eduardo L. G. Moreira [Brésil] ; Filipe C. Matheus [Brésil] ; Adalberto A. Castro [Brésil] ; Roger Walz [Brésil] ; Andreza F. De Bem [Brésil] ; Alexandra Latini [Brésil] ; Carla I. Tasca [Brésil] ; Marcelo Farina [Brésil] ; Rita Raisman-Vozari [France] | The Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP): A New Rodent Model to Test Palliative and Neuroprotective Agents for Parkinson's disease |
| 000359 |
Masahiro Shin [France] ; Caroline Jan [France] ; Carine Jacquard [France] ; Bechir Jarraya [France] ; Jacques Callebert [France] ; Jean-Marie Launay [France] ; Philippe Hantraye [France] ; Philippe Remy [France] ; Stephane Palfi [France] ; Emmanuel Brouillet [France] | Chronic systemic treatment with a high-dose proteasome inhibitor in mice produces akinesia unrelated to nigrostriatal degeneration |
| 000570 |
Serena Santucci [France] ; Nicole Zsiirger [France] ; Joëlle Chabry [France] | β-N-methylamino-L-alanine induced in vivo retinal cell death |
| 000737 |
Dieter Scheller [Allemagne] ; Christine Stichel-Gunkel [Allemagne] ; Hermann Lübbert [Allemagne] ; Gregory Porras [France] ; Paula Ravenscroft [Royaume-Uni] ; Michael Hill [Royaume-Uni] ; Erwan Bezard [France, Royaume-Uni] | Neuroprotective effects of rotigotine in the acute MPTP-lesioned mouse model of Parkinson's disease |
| 000843 |
Charlotte Laloux [France] ; Philippe Derambure [France] ; Jean-Marie Jacquesson [France] ; Régis Bordet [France] ; Alain Destée [France] ; Christelle Monaca [France] | The effects of serotoninergic, noradrenergic, cholinergic and dopaminergic drugs on vigilance states in MPTP-treated mice |
| 000880 |
Alexandre Kreisler [France] ; Patrick Gele [France] ; Jean-Francois Wiart [France] ; Michel Lhermitte [France] ; Alain Destke [France] ; Régis Bordet [France] | Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease : Fenofibrate has a neuroprotective effect, whereas bezafibrate and HMG-CoA reductase inhibitors do not |
| 000A99 |
Pierre Champy [France] ; Alice Melot [France] ; Vincent Guerineau [France] ; Christophe Gleye [France] ; Djibril Fall [France, Sénégal] ; Gunter U. Höglinger [France] ; Merle Ruberg [France] ; Annie Lannuzel [France] ; Olivier Laprevote [France] ; Alain Laurens [France] ; Reynald Hocquemiller [France] | Quantification of acetogenins in Annona muricata linked to atypical parkinsonism in guadeloupe |
| 000B01 |
Carmen Henze [France] ; Andreas Hartmann [France] ; Thomas Lescot [France] ; Etienne C. Hirsch [France] ; Patrick P. Michel [France] | Proliferation of microglial cells induced by 1-methyl-4-phenylpyridinium in mesencephalic cultures results from an astrocyte-dependent mechanism : role of granulocyte macrophage colony-stimulating factor |
| 000B04 |
R. Robichon [France] ; A. Jaafar [France] ; M. Terqui [France] ; P. Brachet [France] ; M. Peschanski [France] | Pig xenografts to the immunocompetent rat brain : Survival rates using distinct neurotoxic lesions in the nigrostriatal pathway and two rat strains |
| 000B05 |
Olga Corti [France] ; Cornelia Hampe [France] ; Frédéric Darios [France] ; Pablo Ibanez [France] ; Merle Ruberg [France] ; Alexis Brice [France] | Parkinson's disease: from causes to mechanisms |
| 000B14 |
Yan-Qin Shen [République populaire de Chine, France] ; Guillaume Hebert [France] ; Yun Su [France] ; Elizabeth Moze [France] ; Pierre J. Neveu [France] ; Kang-Sheng Li [République populaire de Chine] | In mice, production of plasma IL-1 and IL-6 in response to MPTP is related to behavioral lateralization |
| 000C34 |
Erwan Bezard [France] ; Michael P. Hill [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Canada] ; Anne Michel [Belgique] ; Renee Grimee [Belgique] ; Henrik Klitgaard [Belgique] | Levetiracetam improves choreic levodopa-induced dyskinesia in the MPTP-treated macaque |
| 000C46 |
Carlos Barcia [Espagne] ; Angel Sanchez Bahillo [Espagne] ; Emiliano Fernandez-Villalba [Espagne] ; Victor Bautista [Espagne] ; Maximo Poza Y. Poza [Espagne] ; Andrés Fernandez-Barreiro [Espagne] ; Etienne C. Hirsch [France] ; Maria-Trinidad Herrero [Espagne] | Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure |
| 000D35 |
Guillaume Hebert [France] ; Josette Arsaut [France] ; Robert Dantzer [France] ; Jacques Demotes-Mainard [France] | Time-course of the expression of inflammatory cytokines and matrix metalloproteinases in the striatum and mesencephalon of mice injected with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a dopaminergic neurotoxin |
| 000E74 |
| Milestones in Research on Neurotoxins and Neuroprotection: A Tribute to Professor Toshiharu Nagatsu |
| 000F14 |
Martine Barkats [France] ; Stéphanie Millecamps [France] ; Alicia Bilang-Bleuel [France] ; Jacques Mallet [France] | Neuronal transfer of the human Cu/Zn superoxide dismutase gene increases the resistance of dopaminergic neurons to 6-hydroxydopamine |
| 000F41 |
Sophie Callier [France, Canada] ; Maryvonne Le Saux [France] ; Anne-Marie Lhiaubet [France] ; Thérèse Di Paolo [Canada] ; William Rostene [France] ; Didier Pelaprat [France] | Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (MPP+) towards dopaminergic mesencephalic neurones in primary culture |
| 000F50 |
Makoto Naoi [Japon] ; Wakako Maruyama [Japon] ; Yukihiro Akao [Japon] ; HONG YI [Japon] | Dopamine-derived endogenous N-methyl-(R)-salsolinol its role in Parkinson's disease |
| 000F75 |
Toshiharu Nagatsu [Japon] | Amine-related neurotoxins in Parkinson's disease: Past, present, and future |
| 001043 |
Karine Parain [France] ; Véronique Marchand [France] ; Bernard Dumery [France] ; Etienne Hirsch [France] | Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice |
| 001069 |
W. Maruyama [Japon] ; A. A. Boulton [Canada] ; B. A. Davis [Canada] ; P. Dostert [France] ; M. Naoi [Japon] | Enantio-specific induction of apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopaminergic SH-SY5Y cells : Suppression of apoptosis by N-(2-heptyl)-N-methylpropargylamine |
| 001095 |
David Blum [Belgique, France] ; Sakina Torch [France] ; Marie-France Nissou [France] ; Jean-Marc Verna [France] | 6-hydroxydopamine-induced nuclear factor-kappab activation in PC12 cells |
| 001175 |
A. Boireau [France] ; P. Dubedat [France] ; F. Bordier [France] ; A. Imperato [France] ; S. Moussaoui [France] | The protective effect of riluzole in the MPTP model of Parkinson's disease in mice is not due to a decrease in MPP+ accumulation |
| 001192 |
Jeffrey H. Kordower [États-Unis] ; Marina E. Emborg [États-Unis] ; Jocelyne Bloch [États-Unis] ; Shuang Y. Ma [États-Unis] ; YAPING CHU [États-Unis] ; Liza Leventhal [États-Unis] ; Jodi Mcbride [États-Unis] ; Er-Yun Chen [États-Unis] ; Stéphane Palfi [États-Unis] ; Ben Zion Roitberg [États-Unis] ; W. Douglas Brown [États-Unis] ; James E. Holden [États-Unis, Suisse] ; Robert Pyzalski [États-Unis] ; Michael D. Taylor [Suisse] ; Paul Carvey [États-Unis] ; ZAODUNG LING [États-Unis] ; Didier Trono [Suisse] ; Philippe Hantraye [France] ; Nicole Deglon [États-Unis] ; Patrick Aebischer [États-Unis, Suisse] | Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease |
| 001198 |
N. W. Kowall [États-Unis] ; P. Hantraye [France] ; E. Brouillet [France] ; M. F. Beal [États-Unis] ; A. C. Mckee [États-Unis] ; R. J. Ferrante [États-Unis] | MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons |
| 001227 |
Wakako Maruyama [Japon] ; Kumiko Sango [Japon] ; Kinuko Iwasa [Japon] ; Chiyoko Minami [Japon] ; Philippe Dostert [France] ; Masao Kawai [Japon] ; Masataka Moriyasu [Japon] ; Makoto Naoi [Japon] | Dopaminergic neurotoxins, 6,7-dihydroxy-1-(3', 4')-dihydroxybenzyl)-isoquinolines, cause different types of cell death in SH-SY5Y cells : apoptosis was induced by oxidized papaverolines and necrosis by reduced tetrahydropapaverolines |
| 001241 |
Makoto Naoi [Japon] ; Wakako Maruyama [Japon] ; Yukihito Akao [Japon] ; JIN ZHANG [Japon] ; Hasan Parvez [France] | Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopamine neurons |
| 001243 |
P. Jenner [Royaume-Uni] ; B.-Y. Zeng [Royaume-Uni] ; L. A. Smith [Royaume-Uni] ; R. K. B. Pearce [Royaume-Uni] ; B. Tel [Royaume-Uni] ; L. Chancharme [France] ; G. Moachon [France] | Antiparkinsonian and neuroprotective effects of modafinil in the mptp-treated common marmoset |
| 001292 |
V. Ben [France] ; O. Blin [France] ; B. Bruguerolle [France] | Time-dependent striatal dopamine depletion after injection of 6-hydroxydopamine in the rat. Comparison of single bilateral and double bilateral lesions |
| 001328 |
C. Fillebeen [France] ; V. Mitchell [France] ; D. Dexter [Royaume-Uni] ; M. Benaissa [France] ; J.-C. Beauvillain [France] ; G. Spik [France] ; A. Pierce [France] | Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment |
| 001331 |
R. J. Ferrante [États-Unis] ; P. Hantraye [France] ; E. Brouillet [France] ; M. F. Beal [États-Unis] | Increased nitrotyrosine immunoreactivity in substantia nigra neurons in MPTP treated baboons is blocked by inhibition of neuronal nitric oxide synthase |
| 001368 |
E. Bezard [France] ; C. E. Gross [France] ; M.-C. Fournier [France] ; S. Dovero [France] ; B. Bloch [France] ; M. Jaber [France] | Absence of MPTP-lnduced neuronal death in mice lacking the dopamine transporter |
| 001388 |
J. Hugon [France] | Neurologie tropicale et facteurs toxiques |
| 001425 |
H. Bergman [Israël] ; A. Raz [Israël] ; A. Feingold [Israël] ; A. Nini [Israël] ; I. Nelken [Israël] ; D. Hansel [France] ; H. Ben-Pazi [Israël] ; A. Reches [Israël] | Physiology of MPTP tremor |
| 001452 |
T. Boraud [France] ; E. Bezard [France] ; D. Guehl [France] ; B. Bioulac [France] ; C. Gross [France] | Effects of L-DOPA on neuronal activity of the globus pallidus externalis (GPe) and globus pallidus internalis (GPi) in the MPTP-treated monkey |
| 001467 |
N. Aubin [France] ; O. Curet [France] ; A. Deffois [France] ; C. Carter [France] | Aspirin and salicylate protect against MPTP-induced dopamine depletion in mice |
| 001470 |
| Toxicité du glutamate sur des cultures primaires de neurones mésencéphaliques de la substance noire |
| 001548 |
A. Boireau [France] ; F. Bordier [France] ; P. Dubedat [France] ; C. Peny [France] ; A. Imperato [France] | Thalidomide reduces MPTP-induced decrease in striatal dopamine levels in mice |
| 001558 |
E. Bezard [France] ; T. Boraud [France] ; B. Bioulac [France] ; C. E. Gross [France] | Presymptomatic revelation of experimental Parkinsonism |
| 001569 |
E. Bezard [France] ; S. Dovero [France] ; B. Bioulac [France] ; C. E. Gross [France] | Kinetics of nigral degeneration in a chronic model of MPTP-treated mice |
| 001591 |
J. Durlach [France] ; P. Bac [France] ; V. Durlach [France] ; A. Durlach [France] ; M. Bara [France] ; A. Guiet-Bara [France] | Are age-related neurodegenerative diseases linked with various types of magnesium depletion ? |
| 001601 |
E. Bezard [France] ; C. Imbert [France] ; X. Deloire [France] ; B. Bioulac [France] ; C. E. Gross [France] | A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkey |
| 001729 |
M.-T. Herrero [Espagne] ; S. J. Augood ; E. C. Hirsch [France] ; F. Javoy-Agid [France] ; M. R. Luquin [Espagne] ; Yves Agid [France] ; J. A. Obeso [Espagne] ; P. C. Emson | Effects of L-DOPA on preproenkephalin and preprotackykinin gene expression in the MPTP-treated monkey striatum |
| 001739 |
B. A. Faucheux [France] ; M. T. Herrero ; J. Villares [France] ; R. Levy [France] ; F. Javoy-Agid [France] ; J. A. Obeso ; J. J. Hauw [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Autoradiographic localization and density of[125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys |
| 001786 |
A. Boireau [France] ; J.-M. Miquet ; P. Dubedat ; M. Meunier ; A. Doble | Riluzole and experimental parkinsonism : partial antagonism of MPP+-induced increase in striatal extracellular dopamine in rats in vivo |
| 001787 |
A. Boireau [France] ; P. Dubedat ; F. Bordier ; C. Peny ; J.-M. Miquet ; G. Durand ; M. Meunier ; A. Doble | Riluzole and experimental parkinsonism : antagonism of MPTP-induced decrease in central dopamine levels in mice |
| 001810 |
P. Hantraye [France] ; E. Brouillet | Chronic treatment with mitochondrial toxins in primates as experimental models of Parkinson's and Huntington's diseases |
| 001811 |
M. Varastet [France] ; D. Riche [France] ; M. Maziere [France] ; P. Hantraye [France] | Chronic MPTP treatment reproduces in baboons the differential vulnerability of mesencephalic dopaminergic neurons observed in Parkinson's disease |
| 001859 |
I. Marey-Semper [France] ; M. Gelman ; M. Levi-Strauss | The high sensitivity to rotenone of striatal dopamine uptake suggests the existence of a constitutive metabolic deficiency in dopaminergic neurons from the substantia nigra |
| 001861 |
P. Hantraye [France] ; M. Varastet [France] ; M. Peschanski [France] ; D. Riche [France] ; P. Cesaro ; J. C. Willer ; M. Maziere [France] | Stable Parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons |
| 001863 |
P. Gaspar [France] ; A. Febvret [France] ; J. Colombo | Serotonergic sprouting in primate MTP-induced hemiparkinsonism |
| 001864 |
ABDELHAMID BENAZZOUZ [France] ; C. Gross [France] ; J. Feger [France] ; T. Boraud [France] ; B. Bioulac [France] | Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys |
| 001879 |
M. T. Herrero [France] ; I. Perez-Otano ; C. Oset ; A. Kastner [France] ; E. C. Hirsch [France] ; Yves Agid [France] ; M. R. Luquin ; J. A. Obeso ; J. Del Rio | GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys |
| 001888 |
M. T. Herrero [France] ; E. C. Hirsch [France] ; A. Kastner [France] ; M. Ruberg [France] ; M. R. Luquin ; J. Laguna ; F. Javoy-Agid [France] ; J. A. Obeso ; Yves Agid [France] | Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP ? |
| 001947 |
P. P. Michel [France] ; Yves Agid [France] | The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyridinium ion (MPP+) in rat dissociated mesencephalic cultures |
| 001953 |
A. Benazzouz [France] ; C. Gross ; J. Dupont [France] ; B. Bioulac | MPTP induced hemiparkinsonism in monkeys : behavioral, mechanographic, electromyographic and immunohistochemical studies |
| 001A64 |
J. Hugon [France] ; J. M. Vallat | Abnormal distribution of phosphorylated neurofilaments in neuronal degeneration induced by kainic acid |
| 001B31 |
D. Scherman ; F. Darchen ; C. Desnos ; J. P. Henry | 1-Methyl-4-phenylpyridinium is a substrate of the vesicular monoamine uptake system of chromaffin granules |
